The Epoch Times
The Epoch Times
AD
The Epoch Times
Policies & Impacts

27 Drugs Will Be Cheaper for Medicare Recipients From April

27 Drugs Will Be Cheaper for Medicare Recipients From April
Xavier Becerra, secretary of Health and Human Services (HHS), speaks during a press conference at the HHS headquarters in Washington, on June 28, 2022. Nicholas Kamm/AFP via Getty Images
Naveen Athrappully
Naveen Athrappully
Reporter
3/16/2023|Updated: 3/16/2023
0:00

Some beneficiaries of Medicare could start paying less for 27 prescription drugs from next month as their prices have exceeded the rate of inflation.

“Today, the Department of Health and Human Services [HHS], through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower from April 1—June 30, 2023,” said a March 15 CMS press release. “Some people with Medicare who take these drugs may save between $2 and $390 per average dose starting April 1, depending on their individual coverage.”

Naveen Athrappully
Naveen Athrappully
Reporter
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles
USDA, US Army Break Ground on Texas Facility to Combat Flesh-Eating Parasite Spread
Apr 19, 2026
USDA, US Army Break Ground on Texas Facility to Combat Flesh-Eating Parasite Spread
US State Department Issues Travel Advisory for Haiti
Apr 18, 2026
US State Department Issues Travel Advisory for Haiti
USDA Disqualifies 1,562 Retailers, Prevents $835 Million in Fraudulent SNAP Transactions
Apr 18, 2026
USDA Disqualifies 1,562 Retailers, Prevents $835 Million in Fraudulent SNAP Transactions
FDA Updates Classification Level for Recalled Blood Pressure Medicine
Apr 17, 2026
FDA Updates Classification Level for Recalled Blood Pressure Medicine
Related Topics
Medicare
prescription drugs
drug pricing
Inflation Reduction Act of 2022
medicare drugs
AD
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.